Department of Pharmacology and Physiology Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok Thailand.
Research Clusters: Preclinical Toxicity and Efficacy Assessment of Medicines and Chemicals Chulalongkorn University Bangkok Thailand.
Animal Model Exp Med. 2021 Jan 2;4(1):40-46. doi: 10.1002/ame2.12143. eCollection 2021 Mar.
Tiletamine/zolazepam is a dissociative anesthetic combination commonly used in small animals but information is limited in rats. The alpha-2 agonist, dexmedetomidine, has gained popularity in laboratory animal anesthesia. Tramadol is a weak opioid mu agonist. The aim of this study was to assess whether the tiletamine/zolazepam/dexmedetomidine (ZD) combination effectively provides a surgical anesthesia plane comparable to tiletamine/zolazepam/dexmedetomidine with tramadol (ZDT) in a minor procedure in rats.
Rats were induced with ZD or ZDT. After the loss of paw withdrawal, a small incision was made on the rats' left thighs as a surgical stimulus. Rats were maintained under a surgical anesthesia plane by assessing the loss of the paw withdrawal reflex for 45 minutes, then atipamezole was administered. Monitored anesthesia parameters included: (a) physiological parameters - pulse rate (PR), respiratory rate (RR), tissue oxygen saturation (%SpO), and body temperature; (b) duration parameters - induction time, onset and duration of surgical anesthesia plane, onset of recovery, and recovery time.
PR was significantly lower at 10 minutes in ZD and 5 minutes in ZDT groups. No difference was observed for RR, %SpO, and body temperature. Likewise, there were no differences for duration parameters: induction time was less than 3 minutes; onset and duration of surgical anesthesia plane were approximately 5 and 45 minutes, respectively; onset of recovery (time to move) was 51 minutes; and recovery time was 52 minutes, respectively.
These data suggest the ZD combination provides a surgical anesthesia plane comparable to ZDT in a rat incisional pain model.
替来他明/唑拉西泮是一种常用于小动物的分离麻醉剂组合,但在大鼠中信息有限。α-2 激动剂右美托咪定在实验室动物麻醉中越来越受欢迎。曲马多是一种弱阿片 μ 受体激动剂。本研究旨在评估替来他明/唑拉西泮/右美托咪定(ZD)组合是否能在大鼠的小手术中有效提供与替来他明/唑拉西泮/右美托咪定/曲马多(ZDT)相当的手术麻醉平面。
大鼠用 ZD 或 ZDT 诱导。在失去爪退缩反射后,在大鼠左大腿上做一个小切口作为手术刺激。通过评估 45 分钟内的爪退缩反射丧失情况来维持大鼠的手术麻醉平面,然后给予阿替美唑。监测的麻醉参数包括:(a)生理参数-脉搏率(PR)、呼吸率(RR)、组织氧饱和度(%SpO)和体温;(b)持续时间参数-诱导时间、手术麻醉平面的起始和持续时间、恢复开始时间和恢复时间。
在 ZD 组中,PR 在 10 分钟时显著降低,在 ZDT 组中在 5 分钟时显著降低。RR、%SpO 和体温没有差异。同样,持续时间参数也没有差异:诱导时间小于 3 分钟;手术麻醉平面的起始和持续时间分别约为 5 分钟和 45 分钟;恢复开始时间(开始移动的时间)为 51 分钟;恢复时间分别为 52 分钟。
这些数据表明,ZD 组合在大鼠切口疼痛模型中提供了与 ZDT 相当的手术麻醉平面。